Fast Five: Titan Medical licenses out all of its IP to Intuitive, a Medtronic exec moves to Baxter
31 May 2023
Executive Change
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, May 31, 2023.
Fast Five by MassDevice · Titan Medical licenses out all of its IP to Intuitive, a Medtronic exec moves to Baxter
The partnership between HeartBeam and Samsung is a significant development in the field of cardiac care, as it combines HeartBeam’s expertise in cardiac services with Samsung’s global reach and technological prowess. Fast Five hosts Danielle Kirsh and Chris Newmarker have all the details of the partnership.
Concept Medical’s FDA IDE approval for the sirolimus-coated balloon MagicTouch PTA is a significant development in the treatment of superficial femoral artery disease. This approval allows for the investigation of the device’s safety and efficacy in treating this condition. Kirsh and Newmarker discuss the approval and the other indications the device has received in recent months.
Think Surgical’s FDA clearance of its handheld robotic knee surgery device, the TMINI miniature robotic system, represents a major milestone in the field of orthopedic surgery. This innovative technology assists surgeons in performing total knee surgeries with enhanced precision and control. Newmarker explains how the technology works and how it compares to other surgical robots on the market.
The transition of Medtronic’s Cardiovascular Diagnostics and Services President Julie Brewer to Baxter highlights the mobility and talent exchange within the medical device industry. Kirsh and Newmarker talk about the shuffle amidst a time of layoffs.
Titan Medical’s decision to license out all of its intellectual property to Intuitive Surgical signifies a strategic shift in the company’s focus. In a push to further reduce operating costs in the business, Titan Medical also announced some executive changes, including the resignation of its CEO. Newmarker shares all the details of the licensing deal and who’s moving on in the executive suite.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Apple Podcasts
Spotify
SoundCloud
Listen to previous episodes here.
Related: Click here to sign up for our daily e-newsletter to get all the mission-critical news you need in the medical device industry straight to your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.